HomeFundsBeyond Next Ventures
Venture Capital

Beyond Next Ventures

Beyond Next Ventures backs science and technology-driven startups at Pre-Seed through Series A, with a focus on DeepTech, HealthTech, AgriTech, CleanTech, and SpaceTech founders building high-impact, defensible businesses in India.

Ticket size$200K – $2.5M
StagesPre-Seed · Pre-Series A
Sectors6 focus areas

At a glance

Key signals founders use to decide if this investor is worth a conversation.

Where they invest

Stages and sectors this investor typically backs.

Investment thesis

Themes this investor is mapped to across the VC Dekho directory.

All themes →

Portfolio companies

43 companies

Startups this investor has backed — round, amount, date, and source when we can verify them publicly.

Showing 12 of 43

SCOHIA PHARMA
Pharma/Drug Discovery
JPY 3.0 BillionSeries C+Lead
28 May 2026
ATOM Inc.
Robotics/AI
¥3BSeedLead
27 May 2026
FinalLayer
AI
SeedParticipant
28 Oct 2025
Volt14 Solutions
$1.87MPre-Series AParticipant
14 May 2025
Towing
Agri-food Tech
¥1.94 BillionSeries BParticipant
4 May 2025
Biomoneta
Medical
$757KParticipant
4 Jul 2026
Aillis
Medical
Alchemedicine
Biotech / Drug discovery
1 Feb 2021
Anaut
Medical
Series B
15 May 2026
BigHaat
Agriculture / Food
$2mPre-Series A
10 Aug 2020
BiPSEE
Medical
250 million yenSeries A
7 Oct 2021
Bolt Medical
Medical
Acquisition
23 Dec 2022

About Beyond Next Ventures

Background and context for founders evaluating this investor.

Beyond Next Ventures operates a dedicated India investment platform as an extension of its Japan-headquartered venture practice, giving it a distinctive cross-border angle that few India-focused early-stage VCs can match. The firm writes cheques ranging from approximately $200,000 to $2,500,000, covering Pre-Seed through Series A, which means it can lead or participate at the earliest formation stages and follow on as companies gain traction. The sectoral focus spans DeepTech, HealthTech, AgriTech, CleanTech, SpaceTech, and Enterprise SaaS, with a clear preference for startups where science, proprietary technology, or hard IP forms the core of the business. Founders in regulated or capital-intensive domains such as diagnostics, biotech, precision agriculture, or space applications will find the team genuinely conversant with the technical and commercial nuances of these markets. Beyond Next Ventures also brings value beyond capital through its Japan network, which is particularly relevant for startups exploring manufacturing partnerships, regulatory approvals, or enterprise sales in the Japanese market. The portfolio signals an appetite for both B2B and B2C models as long as the technology differentiation is meaningful and the societal impact is visible.

The firm writes cheques ranging from approximately $200,000 to $2,500,000, covering Pre-Seed through Series A, which means it can lead or participate at the earliest formation stages and follow on as companies gain traction.

Notes

MediBuddy, BigHaat, Gig India, Medfin, Gromo, MUSE Diagnostics, ImpactGuru, Myelin Foundry, Faunatech, Lil Goodness, Biomoneta, Generic Aadhaar

Investment criteria

We're interested in deep-tech startups solving important social and environmental challenges. We're also keen to assess startups powering digital transformation of industries.

Data confidence: Unverified – inferred

Investors at Beyond Next Ventures

Partners and principals mapped to this fund in the directory.

Similar funds

Other funds that overlap on stage, sector, or thesis.

Explore related

Jump into stage, sector, and thesis guides connected to this fund.

VC Dekho

Stop guessing. Start matching.

Search funds by stage, sector, cheque size, and thesis — then unlock deeper matching on VC Dekho.

Browse funds